
In April 2015 and January 2018, expert committees examining the request for separate categories for 'innovative' stents had decided that there was no case for sub-categorisation due to the lack of clinical evidence of superiority of the 'innovative' stents over other drug eluting stents.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2q2Hjmd
via
IFTTT
0 comments:
Post a Comment